Stay updated on Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site revision changed from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:36:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:13:00.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2 revision.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:39.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Status updated to Terminated with <75% participation and related dates; an Informed Consent Form PDF is now listed under Study Documents (M.D. Anderson Cancer Center).
    Difference
    1%
    Check dated 2026-02-25T18:25:42.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Administrative site updates were made: Revision: v3.4.2 was added and an older notice (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:15:27.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with references to cc.nih.gov and opm.gov, and updated the site version to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:48:38.000Z thumbnail image

Stay in the know with updates to Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC Clinical Trial page.